Literature DB >> 6117306

Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility.

C S Deacon, M S Lennard, N D Bax, H F Woods, G T Tucker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6117306      PMCID： PMC1401820          DOI： 10.1111/j.1365-2125.1981.tb01240.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Interaction of a series of beta-adrenergic blocking drugs with rat hepatic microsomal monooxygenase.

Authors:  R M Facino; R Lanzani
Journal:  Pharmacol Res Commun       Date:  1979-05

3.  Relationship between difference spectra and metabolism. Barbiturates, drug interaction and species difference.

Authors:  J C Topham
Journal:  Biochem Pharmacol       Date:  1970-05       Impact factor: 5.858

4.  Lack of biological interaction of alprenolol and salicylate in man.

Authors:  G Johnsson; C G Regårdh; L Sölvell
Journal:  Eur J Clin Pharmacol       Date:  1973-06       Impact factor: 2.953

5.  The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man.

Authors:  J B Keenaghan; R N Boyes
Journal:  J Pharmacol Exp Ther       Date:  1972-02       Impact factor: 4.030

6.  Beta-adrenoceptor blockers and the blood-brian barrier.

Authors:  G Neil-Dwyer; J Bartlett; J McAinsh; J M Cruickshank
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

7.  Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists?

Authors:  D B Jack
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

8.  Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients.

Authors:  M Peet; D N Middlemiss; R A Yates
Journal:  Lancet       Date:  1980-11-01       Impact factor: 79.321

9.  Lignocaine and indocyanine green kinetics in patients following myocardial infarction.

Authors:  N D Bax; G T Tucker; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

10.  Impairment of antipyrine clearance in humans by propranolol.

Authors:  D J Greenblatt; K Franke; D H Huffman
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690
View more
  22 in total

Review 1.  beta-blockers. Drug interactions of clinical significance.

Authors:  I Blaufarb; T M Pfeifer; W H Frishman
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaine.

Authors:  G T Tucker; N D Bax; M S Lennard; S Al-Asady; H S Bharaj; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

3.  The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin.

Authors:  N D Bax; M S Lennard; G T Tucker; H F Woods; N R Porter; R G Malia; F E Preston
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

4.  The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.

Authors:  N D Bax; G T Tucker; M S Lennard; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

Review 5.  Clinical pharmacokinetics of labetalol.

Authors:  J J McNeil; W J Louis
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

6.  The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose.

Authors:  N D Bax; M S Lennard; G T Tucker; H F Woods; N R Porter; R G Malia; F E Preston
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

7.  Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

8.  Polymorphic metabolism of beta-adrenoceptor antagonists.

Authors:  J H Silas; M S Lennard; G T Tucker; L E Ramsay; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

9.  Comparison of beta-adrenoceptor antagonists as modulators of drug metabolism: effect of lipophilicity on microsomal phase I and II reactions.

Authors:  J T Ahokas; C Davies; P J Ravenscroft
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

10.  Diazepam/beta-adrenoceptor antagonist interactions.

Authors:  G Hawksworth; T Betts; A Crowe; R Knight; I Nyemitei-Addo; K Parry; J C Petrie; A Raffle; A Parsons
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.